TransThera Tinengotinib Cholangiocarcinoma Priority Review China
CompanyDrug

TransThera Tinengotinib Cholangiocarcinoma Priority Review China

Bio-Sincerity UCAS R&D Center Pharma Synthesis
CompanyDeals

Bio-Sincerity UCAS R&D Center Pharma Synthesis

Sino-Biopharm TQF3250 GLP-1 Capsule Wins FDA Clinical Approval for Weight Loss
CompanyDrug

Sino-Biopharm TQF3250 GLP-1 Capsule Wins FDA Clinical Approval for Weight Loss

Gene-Mink CAR-NK BCMA Therapy Wins China Approval for Multiple Myeloma
CompanyDrug

Gene-Mink CAR-NK BCMA Therapy Wins China Approval for Multiple Myeloma

CSPC SYH2056 FDA Approval Targets Depression with 5-HT2A Agonist
CompanyDrug

CSPC SYH2056 FDA Approval Targets Depression with 5-HT2A Agonist

Antengene XPOVIO sNDA Hong-Kong Approval Expands MM DLBCL Indications
CompanyDrug

Antengene XPOVIO sNDA Hong-Kong Approval Expands MM DLBCL Indications

Duality DB-1324 ADC FDA IND Approval Advances GSK Partnership
CompanyDrug

Duality DB-1324 ADC FDA IND Approval Advances GSK Partnership

NHSA Guangzhou Drug-List Conference Releases 2025 Medical Insurance Formulary
Policy / Regulatory

NHSA Guangzhou Drug-List Conference Releases 2025 Medical Insurance Formulary

Simcere deuremidevir RSV Licensing Deal Targets China Breakthrough
CompanyDeals

Simcere deuremidevir RSV Licensing Deal Targets China Breakthrough

Henlius Fovinaciclib CDK4-6 Breast-Cancer China Commercialization
CompanyDeals

Henlius Fovinaciclib CDK4-6 Breast-Cancer China Commercialization

Hengrui Remimazolam ICU Sedation NMPA Application Accepted
CompanyDrug

Hengrui Remimazolam ICU Sedation NMPA Application Accepted

Novo Nordisk CagriSema Pediatric Obesity Trial to Enroll 460 Children
Others

Novo Nordisk CagriSema Pediatric Obesity Trial to Enroll 460 Children